Ginkgo biloba extract for treatment-resistant schizophrenia.
Comment: Schizophrenia is a chronic, debilitating disease that frequently fails to respond adequately to antipsychotic medication. Schizophrenia is characterized by a wide array of mental symptoms, which are classified as either "positive" or "negative." The positive symptoms, which include delusions, paranoid thoughts, and hallucinations, frequently respond to treatment with antipsychotic drugs. The negative symptoms, on the other hand, which include blunting of the emotions, social withdrawal, and impairment of cognitive function, often fail to respond to treatment. The results of the present study suggest that ginkgo can enhance the effect of clozapine on negative symptoms in patients with treatment-resistant schizophrenia.
Doruk A et al. A placebo-controlled study of extract of ginkgo bilona added to clozapine in patients with treatment-resistant schizophrenia. Int Clin Psychopharmacol. 2008;23:223-227.
by Alan R. Gaby, MD firstname.lastname@example.org
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Literature Review & Commentary|
|Author:||Gaby, Alan R.|
|Article Type:||Brief article|
|Date:||May 1, 2009|
|Previous Article:||Cranberry extract lowers cholesterol levels.|
|Next Article:||Good nutrition enhances recovery from strokes.|